Atherosclerosis
Volume 200, Issue 2 , Pages 403-409 , October 2008

Factors contributing to the risk of cardiovascular disease reflected by plasma adiponectin: Data from the coronary risk factors for atherosclerosis in women (CORA) study

  • Birgit-Christiane Zyriax

      Affiliations

    • Division of Endocrinology and Metabolism of Ageing, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Petra Algenstaedt

      Affiliations

    • Department of Internal Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Utz Florian Hess

      Affiliations

    • Department of Internal Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Mark Schöffauer

      Affiliations

    • University of Heidelberg, School of Medicine, Germany
    • ,
  • Christoph Bamberger

      Affiliations

    • Division of Endocrinology and Metabolism of Ageing, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Heiner Boeing

      Affiliations

    • German Institute of Human Nutrition, Department of Epidemiology, Bergholz-Rehbrücke, Germany
    • ,
  • Eberhard Windler

      Affiliations

    • Division of Endocrinology and Metabolism of Ageing, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • Corresponding Author InformationCorresponding author at: Endokrinologie und Stoffwechsel des Alterns, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. Tel.: +49 163 557 6082; fax: +49 40 571 491 01.

Received 16 October 2007 ,Revised 16 December 2007 ,Accepted 21 December 2007.

References 

  1. Hoffmann K, Zyriax BC, Boeing H, Windler E. A dietary pattern derived to explain biomarker variation is strongly associated with the risk of coronary artery disease. Am J Clin Nutr. 2004;80:633–640
  2. Zyriax BC, Boeing H, Windler E. Nutrition is a powerful independent risk factor for coronary heart disease in women—the CORA study: a population-based case–control study. Eur J Clin Nutr. 2005;59:1201–1207
  3. Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis. 2006;188:231–244
  4. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83
  5. Im JA, Kim SH, Lee JW, et al. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. Metabolism. 2006;55:1546–1550
  6. Imbeault P. Environmental influences on adiponectin levels in humans. Appl Physiol Nutr Metab. 2007;32:505–511
  7. Rothenbacher D, Brenner H, Marz W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J. 2005;26:1640–1646
  8. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51:1884–1888
  9. Kantartzis K, Rittig K, Balletshofer B, et al. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem. 2006;52:1934–1942
  10. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380:24–30
  11. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001;98:2005–2010
  12. Kumada M, Kihara S, Sumitsuji S, et al. Osaka CAD Study Group Association of hypoadiponectinemia with coronary heart diseases in men. Arterioscler Thromb Vasc Biol. 2003;23:85–89
  13. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730–1737
  14. Pilz S, et al. Adiponectin serum concentrations in men with coronary artery disease: The LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Clin Chim Acta. 2006;364:251–255
  15. Lawlor DA, Davey Smith G, Ebrahim S, Thompson C, Sattar N. Plasma adiponectin levels are associated with insulin resistance but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab. 2005;90:5677–5683
  16. Pilz S, Mangge H, Wellnitz B, et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab. 2006;91:4277–4286
  17. Hajer GR, van der Graaf Y, Olijhoek JK, et al. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease. Am Heart J. 2007;154:750.e1–750.e7
  18. Bohlscheid TS, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German Part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;1(Suppl. 26):S59–S70
  19. Kroke A, Klipstein-Grobusch K, Voss S, et al. Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am J Clin Nutr. 1999;70:439–447
  20. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  21. Marques-Vidal P, Mazoyer E, Bongard V, et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care. 2002;25:1371–1377
  22. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;89:2560–2571
  23. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569–2578
  24. Panagiotakos DB, Pitsavos C, Kokkinos P, et al. Consumption of fruits and vegetables in relation to the risk of developing acute coronary syndromes; the CARDIO2000 case–control study. Nutr J. 2003;2:2
  25. Kontogianni MD, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. Relationship between meat intake and the development of acute coronary syndromes: the CARDIO2000 case–control study. Eur J Clin Nutr. 2007;
  26. Qi L, Meigs JB, Liu S, et al. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care. 2006;29:1501–1505
  27. Iwashima Y, Katsuya T, Ishikawa K, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005;45:1094–1100
  28. Baratta R, Amato S, Degano C, et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metabol. 2004;89:2665–2671
  29. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue—relation to obesity, insulin resistance, and tumor necrosis factor-expression. Diabetes. 2003;52:1779–1785
  30. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care. 2002;25:971–976
  31. Adamczak M, Wiecek A, Funahashi T, et al. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003;16:72–75
  32. Huang KC, Chen CL, Chuang LM, et al. Plasma adiponectin levels and blood pressure in nondiabetic adolescent females. J Clin Endocrinol Metabol. 2003;88:4130–4134
  33. Yang WS, Lee WJ, Funahashi T, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res. 2002;10:1104–1110
  34. Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation. 2005;111:747–753
  35. Rathmann W, Herder C. Adiponectin and cardiovascular mortality: evidence for “Reverse Epidemiology”. Horm Metab Res. 2007;39:1–2
  36. Inoue T, Kotooka N, Morooka T, et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol. 2007;100:569–574
  37. Komaba H, Igaki N, Goto S, et al. Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am J Nephrol. 2006;26:476–482

PII: S0021-9150(08)00005-1

doi: 10.1016/j.atherosclerosis.2007.12.033

Atherosclerosis
Volume 200, Issue 2 , Pages 403-409 , October 2008

Article Tools

* Image Usage & Resolution